Skip to main content
. 2021 Sep 20;23(6):537–548. doi: 10.1007/s40272-021-00469-9
Dinutuximab beta can cause adverse events that warrant consideration and management.
Most common adverse events include pain, fever, allergy and capillary leak syndrome.
Practical guidance is provided on the management of the most common adverse events.